These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 7492075)

  • 1. Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy.
    Mukherjee J; Feldmesser M; Scharff MD; Casadevall A
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1398-405. PubMed ID: 7492075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.
    Mukherjee J; Zuckier LS; Scharff MD; Casadevall A
    Antimicrob Agents Chemother; 1994 Mar; 38(3):580-7. PubMed ID: 8203858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages.
    Mukherjee S; Lee SC; Casadevall A
    Infect Immun; 1995 Feb; 63(2):573-9. PubMed ID: 7822024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice.
    Mukherjee S; Lee S; Mukherjee J; Scharff MD; Casadevall A
    Infect Immun; 1994 Mar; 62(3):1079-88. PubMed ID: 8112842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies.
    Mukherjee J; Kozel TR; Casadevall A
    J Immunol; 1998 Oct; 161(7):3557-68. PubMed ID: 9759877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection.
    Feldmesser M; Casadevall A
    J Immunol; 1997 Jan; 158(2):790-9. PubMed ID: 8992996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.
    Mukherjee J; Scharff MD; Casadevall A
    Infect Immun; 1995 Sep; 63(9):3353-9. PubMed ID: 7642262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of 5-flucytosine and capsule-binding monoclonal antibody in the treatment of murine Cryptococcus neoformans infections and in vitro.
    Feldmesser M; Mukherjee J; Casadevall A
    J Antimicrob Chemother; 1996 Mar; 37(3):617-22. PubMed ID: 9182119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.
    Cleare W; Cherniak R; Casadevall A
    Infect Immun; 1999 Jun; 67(6):3096-107. PubMed ID: 10338526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune mice.
    Nussbaum G; Anandasabapathy S; Mukherjee J; Fan M; Casadevall A; Scharff MD
    Infect Immun; 1999 Sep; 67(9):4469-76. PubMed ID: 10456888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antibody to capsular polysaccharide on eosinophilic pneumonia in murine infection with Cryptococcus neoformans.
    Feldmesser M; Kress Y; Casadevall A
    J Infect Dis; 1998 Jun; 177(6):1639-46. PubMed ID: 9607844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins.
    Mukherjee S; Feldmesser M; Casadevall A
    J Infect Dis; 1996 May; 173(5):1222-31. PubMed ID: 8627076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.
    Maitta RW; Datta K; Chang Q; Luo RX; Witover B; Subramaniam K; Pirofski LA
    Infect Immun; 2004 Aug; 72(8):4810-8. PubMed ID: 15271943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.
    Casadevall A; Mukherjee J; Devi SJ; Schneerson R; Robbins JB; Scharff MD
    J Infect Dis; 1992 Jun; 165(6):1086-93. PubMed ID: 1583327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan.
    Casadevall A; DeShaw M; Fan M; Dromer F; Kozel TR; Pirofski LA
    Infect Immun; 1994 Sep; 62(9):3864-72. PubMed ID: 8063403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity mimotope of the polysaccharide capsule of Cryptococcus neoformans identified from an evolutionary phage peptide library.
    Beenhouwer DO; May RJ; Valadon P; Scharff MD
    J Immunol; 2002 Dec; 169(12):6992-9. PubMed ID: 12471134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspects of antigen mimicry revealed by immunization with a peptide mimetic of Cryptococcus neoformans polysaccharide.
    Valadon P; Nussbaum G; Oh J; Scharff MD
    J Immunol; 1998 Aug; 161(4):1829-36. PubMed ID: 9712050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody.
    Goldman DL; Lee SC; Casadevall A
    Infect Immun; 1995 Sep; 63(9):3448-53. PubMed ID: 7642276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice.
    Yuan RR; Spira G; Oh J; Paizi M; Casadevall A; Scharff MD
    Infect Immun; 1998 Mar; 66(3):1057-62. PubMed ID: 9488395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine.
    Pirofski L; Lui R; DeShaw M; Kressel AB; Zhong Z
    Infect Immun; 1995 Aug; 63(8):3005-14. PubMed ID: 7622223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.